Sirna Therapeutics' Other Investors

Sirna Therapeutics raised a round of funding on , .

Sirna Therapeutics develops treatments based on RNAi technology for asthma, diabetes, hepatitis C, macular degeneration and Huntington's Disease.…

Articles about Sirna Therapeutics' Other Investors: